Contineum Therapeutics, Inc.
CTNM
$14.19
-$1.11-7.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 20.76M | 19.63M | 18.77M | 18.19M | 17.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.38M | 66.85M | 68.06M | 67.99M | 66.03M |
| Operating Income | -66.38M | -66.85M | -68.06M | -67.99M | -66.03M |
| Income Before Tax | -57.56M | -58.44M | -59.98M | -59.39M | -56.86M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -57.56 | -58.44 | -59.98 | -59.39 | -56.86 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57.56M | -58.44M | -59.98M | -59.39M | -56.86M |
| EBIT | -66.38M | -66.85M | -68.06M | -67.99M | -66.03M |
| EBITDA | -66.00M | -66.53M | -67.74M | -67.68M | -65.74M |
| EPS Basic | -1.74 | -1.95 | -2.18 | -2.26 | -2.20 |
| Normalized Basic EPS | -1.09 | -1.22 | -1.36 | -1.41 | -1.38 |
| EPS Diluted | -1.74 | -1.95 | -2.18 | -2.26 | -2.20 |
| Normalized Diluted EPS | -1.09 | -1.22 | -1.36 | -1.41 | -1.38 |
| Average Basic Shares Outstanding | 133.79M | 122.21M | 110.74M | 105.70M | 103.31M |
| Average Diluted Shares Outstanding | 133.79M | 122.21M | 110.74M | 105.70M | 103.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |